Skip to content
10-K

Annual Report

NEPHROS, INC. NEPH

0001493152-26-009848

← back to feed
Filed
Mar 12, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted FY 2025 · Dec 31, 2025 10.97M sh
Shares Diluted FY 2025 · Dec 31, 2024 10.6M sh
Operating Cash Flow FY 2025 · Dec 31, 2025 $1.65M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$492K
Cash And Equivalents FY 2025 · Dec 31, 2025 $5.4M
Cash And Equivalents FY 2025 · Dec 31, 2024 $3.76M
Current Liabilities FY 2025 · Dec 31, 2025 $2.77M
Current Liabilities FY 2025 · Dec 31, 2024 $1.56M
Total Liabilities FY 2025 · Dec 31, 2025 $3.44M
Total Liabilities FY 2025 · Dec 31, 2024 $2.63M
Current Assets FY 2025 · Dec 31, 2025 $11.22M
Current Assets FY 2025 · Dec 31, 2024 $8.3M
Total Assets FY 2025 · Dec 31, 2025 $13.64M
Total Assets FY 2025 · Dec 31, 2024 $11.21M
Eps Diluted FY 2025 · Dec 31, 2025 $0.11
Eps Diluted FY 2025 · Dec 31, 2024 $0.01
Eps Basic FY 2025 · Dec 31, 2025 $0.11
Eps Basic FY 2025 · Dec 31, 2024 $0.01
Sga Expense FY 2025 · Dec 31, 2025 $9M
Sga Expense FY 2025 · Dec 31, 2024 $7.68M
Rd Expense FY 2025 · Dec 31, 2025 $1.34M
Rd Expense FY 2025 · Dec 31, 2024 $906K
Net Income FY 2025 · Dec 31, 2025 $1.19M
Net Income FY 2025 · Dec 31, 2024 $74K
Operating Income FY 2025 · Dec 31, 2025 $1.15M
Operating Income FY 2025 · Dec 31, 2024 $6K
Gross Profit FY 2025 · Dec 31, 2025 $11.63M
Gross Profit FY 2025 · Dec 31, 2024 $8.72M
Cost Of Revenue FY 2025 · Dec 31, 2025 $7.16M
Cost Of Revenue FY 2025 · Dec 31, 2024 $5.44M
Revenue FY 2025 · Dec 31, 2025 $18.79M
Revenue FY 2025 · Dec 31, 2024 $14.16M
Capex FY 2025 · Dec 31, 2024 $55K